{
    "root": "b6c8cde8-6e8b-40fc-8957-3870e2509dce",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clozaril",
    "value": "20250325",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "CLOZAPINE",
            "code": "J60AR2IKIC"
        }
    ],
    "indications": "clozaril atypical antipsychotic indicated : • treatment-resistant schizophrenia . efficacy established active-controlled study . ( 1.1 , 14.1 ) • reducing suicidal behavior patients schizophrenia schizoaffective disorder . efficacy established active-controlled study . ( 1.2 , 14.2 )",
    "contraindications": "• starting dose : 12.5 mg daily twice daily . ( 2.2 ) • cautious titration divided schedule . ( 2.2 , 5.3 ) • titration : increase total daily increments 25 mg 50 mg per day , well-tolerated . ( 2.2 ) • target dose : 300 mg 450 mg per day , divided doses , end 2 weeks . ( 2.2 ) • subsequent increases : increase increments 100 mg less , twice weekly . ( 2.2 ) • maximum daily dose : 900 mg ( 2.2 )",
    "warningsAndPrecautions": "clozaril ® ( clozapine ) tablets 25 mg round , pale-yellow , uncoated tablet . debossed “ clozaril ” periphery one side . debossed facilitated score “ 25 ” side . bottle 100 ndc 69809-0126-05 100 mg round , pale-yellow , uncoated tablet . debossed “ clozaril ” periphery one side . debossed facilitated score “ 100 ” side . bottle 100 ndc 69809-0127-05",
    "adverseReactions": "clozaril contraindicated patients history serious hypersensitivity clozapine ( e.g . , photosensitivity , vasculitis , erythema multiforme , stevens-johnson syndrome ) component clozaril [ ( 6.2 ) ] .",
    "indications_original": "CLOZARIL is an atypical antipsychotic indicated for: • Treatment-resistant schizophrenia. Efficacy was established in an active-controlled study. ( 1.1 , 14.1 ) • Reducing suicidal behavior in patients with schizophrenia or schizoaffective disorder. Efficacy was established in an active-controlled study. ( 1.2 , 14.2 )",
    "contraindications_original": "• Starting Dose: 12.5 mg once daily or twice daily. ( 2.2 ) • Use cautious titration and divided dosage schedule. ( 2.2 , 5.3 ) • Titration: increase the total daily dosage in increments of 25 mg to 50 mg per day, if well-tolerated. ( 2.2 ) • Target dose: 300 mg to 450 mg per day, in divided doses, by the end of 2 weeks. ( 2.2 ) • Subsequent increases: increase in increments of 100 mg or less, once or twice weekly. ( 2.2 ) • Maximum daily dose: 900 mg ( 2.2 )",
    "warningsAndPrecautions_original": "CLOZARIL ® (clozapine) Tablets \n                                       \n                                    \n                                 \n                                 \n                              \n                              \n                                 \n                                    \n                                       \n                                          25 mg\n                                       \n                                    \n                                 \n                                 \n                              \n                              \n                                 \n                                    Round, pale-yellow, uncoated tablet. Debossed with “CLOZARIL” once on the periphery of one side. Debossed with a facilitated score and “25” once on the other side.\n                                 \n                                 \n                              \n                              \n                                 \n                                    Bottle of 100\n                                 \n                                 \n                                    NDC 69809-0126-05\n                                 \n                              \n                              \n                                 \n                                    \n                                       \n                                          100 mg\n                                       \n                                    \n                                 \n                                 \n                              \n                              \n                                 \n                                    Round, pale-yellow, uncoated tablet. Debossed with “CLOZARIL” once on the periphery of one side. Debossed with a facilitated score and “100” once on the other side.\n                                 \n                                 \n                              \n                              \n                                 \n                                    Bottle of 100\n                                 \n                                 \n                                    NDC 69809-0127-05",
    "adverseReactions_original": "CLOZARIL is contraindicated in patients with a history of serious hypersensitivity to clozapine (e.g., photosensitivity, vasculitis, erythema multiforme, or Stevens-Johnson Syndrome) or any other component of CLOZARIL [see Adverse Reactions (6.2)]."
}